APPLIED THERAPEUTICS INC's ticker is APLT and the CUSIP is 03828A101. A total of 36 filers reported holding APPLIED THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,013,934 | +101.5% | 808,809 | +3.6% | 0.05% | +125.0% |
Q2 2023 | $999,412 | +57.8% | 780,791 | 0.0% | 0.02% | +60.0% |
Q1 2023 | $633,300 | +39.7% | 780,791 | +30.9% | 0.02% | +36.4% |
Q4 2022 | $453,477 | -30.6% | 596,680 | -15.0% | 0.01% | -35.3% |
Q3 2022 | $653,000 | -1.8% | 701,680 | 0.0% | 0.02% | -10.5% |
Q2 2022 | $665,000 | -55.1% | 701,680 | 0.0% | 0.02% | -48.6% |
Q1 2022 | $1,481,000 | -76.4% | 701,680 | 0.0% | 0.04% | -74.5% |
Q4 2021 | $6,280,000 | -46.1% | 701,680 | 0.0% | 0.14% | -40.8% |
Q3 2021 | $11,648,000 | -20.1% | 701,680 | 0.0% | 0.24% | -14.9% |
Q2 2021 | $14,581,000 | +10.8% | 701,680 | 0.0% | 0.29% | +0.3% |
Q1 2021 | $13,160,000 | -6.0% | 701,680 | +10.4% | 0.29% | -3.4% |
Q4 2020 | $13,995,000 | -32.0% | 635,837 | -35.9% | 0.30% | -43.1% |
Q3 2020 | $20,585,000 | -42.6% | 991,573 | 0.0% | 0.52% | -46.9% |
Q2 2020 | $35,845,000 | +29.7% | 991,573 | +17.2% | 0.98% | -14.0% |
Q1 2020 | $27,646,000 | +4890.3% | 845,700 | +4062.9% | 1.14% | +6250.0% |
Q4 2019 | $554,000 | – | 20,315 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 1,025,464 | $19,227,000 | 12.53% |
EMERALD MUTUAL FUND ADVISERS TRUST | 644,572 | $12,089,000 | 0.40% |
Orbimed Advisors | 2,257,387 | $42,337,000 | 0.40% |
EMERALD ADVISERS, LLC | 554,279 | $10,396,000 | 0.38% |
Rock Springs Capital Management LP | 701,680 | $13,160,000 | 0.29% |
DSAM Partners (London) Ltd | 67,125 | $1,259,000 | 0.23% |
AlphaCentric Advisors LLC | 33,000 | $619,000 | 0.21% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 639,458 | $11,993,000 | 0.18% |
Artal Group S.A. | 400,000 | $7,502,000 | 0.13% |
Virtus ETF Advisers LLC | 12,438 | $233,000 | 0.10% |